What You Should Know:– Apixio, a leading AI platform that powers value-based care launches its new Apicare Post-Visit™ offering, an EHR-integrated intelligent workflow solution for health plans and providers. With the Centers for Medicare…
Continue Reading
Pete speaks with a lot of people who have a clinical background. They have done the hard work to be a doctor, a nurse, or an allied health provider. They go through the training, they get all the…
Continue Reading
With Clinical Laboratory Evaluation Program assay validation, the company’s Clinical Laboratory Improvement Amendments-certified lab can begin testing patient samples.WHY IT MATTERS
Along with New York State Department of Health clinical and analytical validation of this use of array morphology, the results of the PDxBr test were reproducible.
“Consistent with our mission of improving healthcare, PDxBr has shown to be an effective prognostic tool to further improve risk stratification over current histopathology methods,” said Wayne Brinster, CEO of PreciseDx, in an announcement.
The company says the AI technology has now proven its ability to enhance invasive breast cancer pathology interpretation with objective, quantifiable and accurate…
AI healthcare software company VinBrain, a company backed by Vietnam’s largest conglomerate Vingroup, has entered into a formal collaboration with Microsoft.WHAT IT’S ABOUT
According to a press release, the partnership, which is a first for the global tech company in Vietnam, will work on three areas of AI healthcare: data sharing, cross-product validation, and R&D.
VinBrain will leverage DrAid, its suite of AI-powered pathology solutions which can detect 21 disease indicators of the heart, lungs and bone. The US FDA-approved platform is being used by around 2,000 doctors and more than 100 hospitals in Vietnam.
The AI platform runs on a dataset of over…
